National Institutes of Health(NIH),under the SHIFT initiative,has granted two Small Business Innovative Research(SBIR)Phase I awards,totaling$800k over 2 years,to Circulomics. Circulomics will use the grants to develop its Ligo-miR ...
Tags: NIH, SHIFT, SBIR, Ligo miR microRNA assay technology
Havilah Resources NL announced that a significant new iron ore discovery at the Grants prospect in the Braemar Iron Ore Province in northeastern South Australia.The discovery has no overburden and is 8 kilometer from the Transcontinental ...
Tags: havilah resources NL, metallurgy, mineral energy, discovery
Global Technologies Group, Inc., announces the results of the live run at the cement plant incorporating the MBS technology for Mercury capture in the cement plant emission gasses. This final report is the result of the compilation of ...
Tags: MBS technology, Mercury capture, cement plant emission gasses
This week's featured reports from the just-food store includes research on consumer and innovation trends and opportunities in functional foods. TRENDS Experimentation: Consumer & Innovation Trends This report provides a unique blend ...
Tags: Consumer and Innovation Trends, Opportunities in Functional Foods
Sorin Group has obtained marketing rights to its Mitroflow aortic pericardial heart valve in Japan, following the approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The bioprosthetic heart valve, which is ...
Tags: PMDA, heart valve, Japan Lifeline
Mauna Kea Technologies has obtained CE mark for its UroFlex confocal miniprobe, designed for use in urological applications. The optical biopsy probe, the first urological probe in the Cellvizio portfolio, provides physicians with an ...
Tags: Mauna Kea Technologies, CE mark, TURBT
Developed through a successful Freight Smart Grant application by Cannon Logistics, IceCOLD Synthetic Catalyst Technology (IceCOLD) has proven itself successful. The grants were offered as a joint initiative by the Queensland Transport and ...
Tags: joint initiative, innovative solutions, carbon emissions
The US Patent and Trademark Office (USPTO) has granted new patent No. #8241330 to Lanx's Aspen MIS Fusion system, designed to support posterolateral fusions and interbody fusions. The Aspen system features proprietary spiked fixation ...
Tags: USPTO, MIS Fusion system, posterolateral fusions, interbody fusions
Roche Group member, Genentech has received US Food and Drug Administration (FDA) official approval of priority review designation for trastuzumab emtansine Biologics License Application (BLA). Trastuzumab Emtansine is designed to treat ...
The US Patent and Trademark Office (USPTO) has granted a US Patent NO 8,185,485 B2 to Lifeline Biotechnologies' device used for analyzing thermal data based on breast surface temperature for the detection for use in determining cancerous ...
Tags: USPTO, Lifeline Biotechnologies'device, analyzing, surface temperature
CSL Behring has received FDA orphan drug designation for its recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP). The designation was granted for the treatment and prophylaxis of bleeding episodes in ...
Tags: CSL Behring, rIX-FP, hemophilia B
Threshold Pharmaceutical has received orphan drug designation for TH-302, a cancer drug, from the US FDA. Threshold is presently testing TH-302 along with a commonly used chemotherapeutic agent, doxorubicin, in a late-stage trial to treat ...
Limited Pre-badge Mailing Available for LED Industry’s Largest Event Online registration is now open for the 2013 LED CHINA Exhibition—the world’s largest professional event showcasing the completeLED supply chain and ...
Tags: LED, Lighting, LED Display, LED chip, 2013 LED CHINA
The US Patent and Trademark Office (USPTO) has granted a patent for the use of Aeterna Zentaris' oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency (AGHD). AEZS-130, which has been granted ...
Tags: AEZS-130, growth hormone deficiency, AGHD
The US Food and Drug Administration (FDA) has granted accelerated approval to Talon Therapeutics' Marqibo (vinCRIStine sulfate LIPOSOME injection). Marqibo, a sphingomyelin/cholesterol liposome-encapsulated formulation of vincristine ...